破解脂质组:癌症治疗中的新铁灭策略
Borys Varynskyi1,2, Joel A Schick1
1Genetics and Cellular Engineering Group, Research Unit Signaling and Translation, Helmholtz Zentrum Munich, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany.
Biomedicines
|March 28, 2024
概括
癌细胞可以通过重新定位对铁灭症敏感的脂质来向死亡. 本综述探讨了新陈代谢途径,如新生脂质生成和解抑制,作为铁灭症敏感化的治疗标.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 代谢工程是代谢工程.
背景情况:
- 代谢途径的重定向是癌症治疗的一个关键策略.
- 铁亡是一种受调节的细胞死亡形式,通过向癌细胞脂质代谢,为治疗提供了新的途径.
研究的目的:
- 审查癌细胞与铁亡敏感化相关的历史脂质和代谢变化.
- 为了确定关键的亲铁菌基因和途径作为治疗点.
- 探索新的漏洞,如解抑制,用于增强铁亡.
主要方法:
- 文献综述侧重于脂管学,代谢变化和癌症中的铁.
- 识别和分析亲铁植物基因和代谢途径.
- 讨论涉及脂质组操纵的治疗策略.
主要成果:
- 新生脂质生成被突出显示为ferroptosis敏感化的目标.
- 提出了一个新的漏洞,将解抑制与增加的铁灭敏感性联系起来.
- 确定了关键的亲铁菌途径和基因作为潜在的治疗标.
结论:
- 准特定的代谢途径和脂质配置文件可以使癌细胞对铁亡敏感.
- 在癌症治疗中,操纵脂质组是一种可行的策略,可以克服癌症治疗中的铁灭抵抗性.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


